Amino Acid, Peptide, or Protein – Page 72

Novo Nordisk Faces Scrutiny Over High Prices of Ozempic and Wegovy

12 months ago talkbio0Tagged Diabetes, Nordisk, Obesity, Prices, Sanders, Senator Bernie, Wegovy

Novo Nordisk, Ozempic, Wegovy, drug prices, Senator Bernie Sanders, diabetes, obesity

Gilead’s Strategic Focus: CymaBay Liver Drug, Trodelvy Data, and Long-Acting PrEP in 2023

12 months ago talkbio0Tagged CymaBay, Gilead, liver drug, PREP gene, readouts, Strategic Focus, Trodelvy

Gilead, CymaBay, liver drug, Trodelvy, readouts, long-acting PrEP, 2023, strategic focus.

GSK Files Lawsuit Against Pfizer and BioNTech for Alleged COVID-19 Vaccine Patent Violation

12 months ago talkbio0Tagged BioNTech, COVID19 (disease), infringement, Intellectual Property, Legal patent, Pfizer, SmithKline Beecham, Vaccines

GSK, Pfizer, BioNTech, COVID-19, patent infringement, vaccine, lawsuit, intellectual property

Merck & Co.’s Q1 Success Driven by Keytruda, Ups 2024 Outlook

12 months ago talkbio0Tagged Cancer Therapeutic Procedure, Co., earnings, Keytruda, Projections and Predictions

Merck & Co., Q1 earnings, Keytruda, pharmaceuticals, cancer treatment, 2024 forecast

Senator Sanders Investigates Skyrocketing Costs of Novo Nordisk’s Diabetes and Weight Loss Drugs

1 year ago talkbio0Tagged Affordability, Diabetes, Evaluation, Health care facility, Nordisk, Novos, Prices, Senator Bernie Sanders, Wegovy

Senator Bernie Sanders, Novo Nordisk, diabetes, weight loss, drug prices, Novos Ozempic, Wegovy, investigation, healthcare costs, affordability

From Alpine’s Elite Data Room to Vertex’s VIP: A Shift in Biotech Dominance

1 year ago talkbio0Tagged data room, Dominance, exclusivity, vasoactive intestinal peptide

Alpine, Vertex, biotech, data room, exclusivity, VIP, shift, dominance.

Eli Lilly Expands Manufacturing Capacity with Nexus Plant Acquisition Amid Ongoing Mounjaro and Zepbound Supply Challenges

1 year ago talkbio0Tagged Acquisition (action), Capacity, Drug Industry, Drug shortages, Eli, Eli Lilly, Manufacture, Mounjaro, Nexus manufacturing, Plants, Wisconsin, Zepbound

Eli Lilly, Nexus manufacturing plant, Wisconsin, Mounjaro, Zepbound, drug shortages, manufacturing capacity, pharmaceutical industry, acquisition

BenevolentAI Downsizes Operations, Cuts 30% of Workforce Amidst Funding Challenges

1 year ago talkbio0Tagged AI, Artificial Intelligence, BenevolentAI, Drug Discovery, GTPase-Activating Proteins, research

BenevolentAI, layoffs, workforce reduction, funding gap, US site closure, AI research, drug discovery

Incyte Expands Portfolio with $750 Million Acquisition of Escient, a Pioneer in Immune and Neuro Biotechnology

1 year ago talkbio0Tagged Acquisition (action), Biotechnology, Drug Development, Escient, expansion, G-Protein-Coupled Receptors, Immune system, Incyte, Neuroscience discipline, portfolio, targets

Incyte, Escient, biotechnology, immune system, neuroscience, acquisition, deal, $750 million, portfolio expansion, drug development, therapeutics, GPCR targets.

ImmunityBio’s Innovative IL-15 Superagonist Receives FDA Approval for Non-Muscle Invasive Bladder Cancer Treatment

1 year ago talkbio0Tagged Approved, Carcinoma of urinary bladder, invasive, ImmunityBio, Immunotherapy, Interleukin-15, Malignant Neoplasms, Non-Muscle, Non-Muscle Invasive Bladder Neoplasms, Superagonist, United States Food and Drug Administration

ImmunityBio, FDA Approval, IL-15 Superagonist, Non-Muscle Invasive Bladder Cancer (NMIBC), Immunotherapy, Cancer Treatment